Page last updated: 2024-08-24

plerixafor and chi 1043

plerixafor has been researched along with chi 1043 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Maeyer, M; Debyser, Z; Desadeleer, C; Hombrouck, A; Van Remoortel, B; Voet, A; Witvrouw, M	1

Other Studies

1 other study(ies) available for plerixafor and chi 1043

Article	Year
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Cell Line; Drug Resistance, Viral; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Models, Molecular; Mutation; Naphthyridines; Quinolones; Virus Replication	2008

Article

Year

Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137.

Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

Topics: Cell Line; Drug Resistance, Viral; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Models, Molecular; Mutation; Naphthyridines; Quinolones; Virus Replication

2008